Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistent SARS-2 infections contribute to long COVID-19
John J. L. Jacobs
Medical Hypotheses (2021) Vol. 149, pp. 110538-110538
Open Access | Times Cited: 92

Showing 26-50 of 92 citing articles:

A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases
Subodh Kumar Samrat, Qamar Bashir, Ran Zhang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 12
The demographic, laboratory and genetic factors associated with long Covid-19 syndrome: a case–control study
Ensiye Torki, Fahimeh Hoseininasab, Marjan Moradi, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Serological Biomarkers at Hospital Admission Are Not Related to Long-Term Post-COVID Fatigue and Dyspnea in COVID-19 Survivors
César Fernández‐de‐las‐Peñas, Pablo Ryan, Jorge Rodríguez‐Jiménez, et al.
Respiration (2022) Vol. 101, Iss. 7, pp. 658-665
Open Access | Times Cited: 20
The Challenge of Long COVID-19 Management: From Disease Molecular Hallmarks to the Proposal of Exercise as Therapy
R. Scurati, Nadia Papini, Paola Giussani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12311-12311
Open Access | Times Cited: 20
Unveiling the Mysteries of Long COVID Syndrome: Exploring the Distinct Tissue and Organ Pathologies Linked to Prolonged COVID-19 Symptoms
Fnu Sapna, Fnu Deepa, F. N. U. Sakshi, et al.
Cureus (2023)
Open Access | Times Cited: 11
An agent-based modeling approach for lung fibrosis in response to COVID-19
Mohammad Aminul Islam, Michael Getz, Paul Macklin, et al.
PLoS Computational Biology (2023) Vol. 19, Iss. 12, pp. e1011741-e1011741
Open Access | Times Cited: 10
UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease
Chang Yi Wang, Be-Sheng Kuo, Yu-Hsiang Lee, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108887-108887
Open Access | Times Cited: 3
Experiences of workers with post-COVID-19 symptoms can signpost suitable workplace accommodations
Jennifer Lunt, Sally Hemming, James Elander, et al.
International Journal of Workplace Health Management (2022) Vol. 15, Iss. 3, pp. 359-374
Open Access | Times Cited: 17
Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection
Catherine Chen, Aisah Amelia, George W. Ashdown, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 20
Direct, indirect, post-infection damages induced by coronavirus in the human body: an overview
Sivan Padma Priya, Priyanka Sunil, Sudhir Varma, et al.
VirusDisease (2022) Vol. 33, Iss. 4, pp. 429-444
Open Access | Times Cited: 15
Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19
Hythem Sidky, David Sahner, Andrew T. Girvin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Incidence of persistent SARS-CoV-2 gut infection in patients with a history of COVID-19: Insights from endoscopic examination
Mohamed Hany, Eman Sheta, Ahmed Talha, et al.
Endoscopy International Open (2023) Vol. 12, Iss. 01, pp. E11-E22
Open Access | Times Cited: 8
Potential Anti-Inflammatory and Anti-Fatigue Effects of an Oral Food Supplement in Long COVID Patients
Annalisa Noce, Giulia Marrone, Manuela Di Lauro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 463-463
Open Access | Times Cited: 2
Multidisciplinary Management Strategies for Long COVID: A Narrative Review
Christian Prusinski, Dan Yan, Johana Klasová, et al.
Cureus (2024)
Open Access | Times Cited: 2
Reactivation of herpesvirus type-6 and IgA/IgM-mediated responses to activin-A underpin Long COVID, including affective symptoms and chronic fatigue syndrome
Aristo Vojdani, Abbas F. Almulla, Bo Zhou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Intrinsic factors behind long COVID: III. Persistence of SARS‐CoV‐2 and its components
Nawal Abd El‐Baky, Amro Abd Al Fattah Amara, Vladimir N. Uversky, et al.
Journal of Cellular Biochemistry (2023) Vol. 125, Iss. 1
Closed Access | Times Cited: 7
Coronavirus persistence in human respiratory tract and cell culture: An overview
Adriana Gaspar-Rodríguez, Ana Padilla-González, Evelyn Rivera-Toledo
The Brazilian Journal of Infectious Diseases (2021) Vol. 25, Iss. 5, pp. 101632-101632
Open Access | Times Cited: 17
The Role of Interferons in Long Covid Infection
Mohammad Karbalaeimahdi, Safar Farajnia, Nasrin Bargahi, et al.
Journal of Interferon & Cytokine Research (2023) Vol. 43, Iss. 2, pp. 65-76
Closed Access | Times Cited: 6
Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome
Mariann Gyöngyösi, Dominika Lukovic, Julia Mester-Tonczar, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Epidemiologic Assessment of Pediatric Inflammatory Bowel Disease Presentation in NYC During COVID-19
Janet E. Rosenbaum, Kenny Castro Ochoa, Faria Hasan, et al.
Journal of Pediatric Gastroenterology and Nutrition (2023) Vol. 76, Iss. 5, pp. 622-626
Open Access | Times Cited: 5
Progress and treatment of “long COVID” in non‐hospitalized patients: A single‐center retrospective cohort study
Rie Ono, Ryutaro Arita, Shin Takayama, et al.
Traditional & Kampo Medicine (2023) Vol. 10, Iss. 2, pp. 150-158
Open Access | Times Cited: 5
Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post–COVID-19 Syndrome
Martin Achleitner, Nina K. Mair, Juliane Dänhardt, et al.
Open Forum Infectious Diseases (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development
Niel A. Karrow, Umesh K. Shandilya, Steven Pelech, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1351-1351
Open Access | Times Cited: 13
Persistent Autoimmune Activation and Proinflammatory State in Post-COVID Syndrome
Yeny Acosta‐Ampudia, Diana M. Monsalve, Manuel Rojas, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 13
Clinical characteristics, anti-SARS-CoV-2 IgG titers, and inflammatory markers in individuals with post-COVID-19 condition in Kenya: a cross-sectional study
Martin Theuri, Eric M. Ndombi, Peris Thamaini, et al.
PeerJ (2024) Vol. 12, pp. e17723-e17723
Open Access | Times Cited: 1

Scroll to top